To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATP6V0A2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
186 supporting clones for gene ATP6V0A2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC068531 Placenta, normal .a 1 to 3057 1 to 3057 exact tiling clone, available from MGC, AAA   3057/3057
(100 %)
3 diff
(100.0 %id)
CB987966 Human Placenta, placenta .a 1 to 642 28 to 675       648/811
(79 %)
23 diff
(97.2 %id)
CB960860 Human Placenta, placenta .a 1 to 665 28 to 702       675/812
(83 %)
23 diff
(97.2 %id)
CD109397 Human Placenta, placenta .a 1 to 537 28 to 570       543/860
(63 %)
16 diff
(98.2 %id)
NM_012463.3   .a 1 to 6539 1 to 6539 exact RefSeq, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 6539/6539
(100 %)
0 diff
(100 %id)
DR005788 Prostate .a 37 to 776 1 to 739       739/743
(99 %)
10 diff
(98.7 %id)
BG611798 adenocarcinoma, Prostate .a 38 to 680 1 to 645   available from MGC,   645/686
(94 %)
9 diff
(98.7 %id)
BU598115 mixed (pool of 40 RNAs) .a 45 to 740 1 to 704       702/934
(75 %)
26 diff
(97.3 %id)
AK289391   .a 86 to 3057 1 to 2972 L669P     2972/2972
(100 %)
5 diff
(99.9 %id)
DA020718   .a 87 to 647 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AW968282   .a 90 to 680 1 to 591       591/655
(90 %)
8 diff
(98.8 %id)
AW971698   .a 90 to 680 1 to 591       591/663
(89 %)
7 diff
(99.0 %id)
BF446493 carcinoid, lung .a 95 to 577 1 to 483     Submitted on the opposite strand 483/483
(100 %)
5 diff
(99.0 %id)
AA258239 germinal center B cell .a 96 to 543 1 to 451     Submitted on the opposite strand 451/459
(98 %)
22 diff
(95.3 %id)
AA287485 germinal center B cell .a 96 to 682 1 to 571     Submitted on the opposite strand 571/618
(92 %)
25 diff
(96.0 %id)
AI698524 pooled .a 96 to 486 1 to 387     Submitted on the opposite strand 387/389
(99 %)
16 diff
(95.9 %id)
AW072555 pooled .a 96 to 659 1 to 564     Submitted on the opposite strand 564/564
(100 %)
1 diff
(99.9 %id)
AW340585 pooled .a 96 to 761 1 to 667     Submitted on the opposite strand 667/667
(100 %)
17 diff
(97.5 %id)
AW629233 pooled .a 96 to 493 1 to 400     Submitted on the opposite strand 400/401
(99 %)
8 diff
(98.1 %id)
AW138826   .a 97 to 680 1 to 586     Submitted on the opposite strand 586/594
(98 %)
4 diff
(99.4 %id)
BI835655 pooled pancreas and spleen .a 104 to 240 137 to 1     Submitted on the opposite strand 137/137
(100 %)
0 diff
(100 %id)
AI809764 pooled .a 108 to 655 1 to 549     Submitted on the opposite strand 549/549
(100 %)
8 diff
(98.6 %id)
AI382714 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 135 to 347 1 to 213     Submitted on the opposite strand 213/213
(100 %)
2 diff
(99.1 %id)
AW471214 pooled .a 144 to 680 1 to 537     Submitted on the opposite strand 537/537
(100 %)
30 diff
(94.5 %id)
AA889044 pooled .a 153 to 680 1 to 522     Submitted on the opposite strand 522/534
(97 %)
22 diff
(95.9 %id)
AA768168 germinal center B cell .a 166 to 480 1 to 315     Submitted on the opposite strand 315/315
(100 %)
13 diff
(95.9 %id)
BE504422 carcinoid, lung .a 169 to 579 1 to 411     Submitted on the opposite strand 411/411
(100 %)
1 diff
(99.8 %id)
AL121185 melanoma (MeWo cell line) .a 186 to 502 317 to 1     Submitted on the opposite strand 317/317
(100 %)
8 diff
(97.5 %id)
AA827212 germinal center B cell .a 193 to 460 1 to 267     Submitted on the opposite strand 267/267
(100 %)
16 diff
(94.1 %id)
AA812005 germinal center B cell .a 201 to 617 1 to 416     Submitted on the opposite strand 416/416
(100 %)
8 diff
(98.1 %id)
AA286698 germinal center B cell .a 227 to 691 480 to 16     Submitted on the opposite strand 465/480
(96 %)
2 diff
(99.6 %id)
AF112972   .a 244 to 2961 1 to 2718 L428W     2718/2718
(100 %)
5 diff
(99.9 %id)
TI_1948237361   .a 248 to 1075 126 to 957       832/1274
(65 %)
35 diff
(97.3 %id)
TI_1948237362   .a 248 to 1210 134 to 1111       978/1254
(77 %)
49 diff
(96.1 %id)
TI_1948237803   .a 248 to 785 125 to 666       542/1292
(41 %)
60 diff
(95.4 %id)
TI_1948238041   .a 248 to 1269 136 to 1158       1023/1271
(80 %)
58 diff
(95.5 %id)
TI_1948238042   .a 248 to 1272 136 to 1171       1036/1227
(84 %)
40 diff
(96.8 %id)
EL736808 mixed .a 249 to 855 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
BF222620 Prostate .a 251 to 529 1 to 279     Submitted on the opposite strand 279/280
(99 %)
13 diff
(95.4 %id)
AA259083 germinal center B cell .a 252 to 680 455 to 27     Submitted on the opposite strand 429/455
(94 %)
1 diff
(99.8 %id)
AA769000 germinal center B cell .a 362 to 580 1 to 218     Submitted on the opposite strand 218/218
(100 %)
13 diff
(94.1 %id)
BQ307998 breast .a 366 to 680 321 to 5       317/324
(97 %)
7 diff
(97.9 %id)
AA746281 germinal center B cell .a 412 to 649 239 to 1     Submitted on the opposite strand 239/239
(100 %)
3 diff
(98.8 %id)
DA737084   .a 466 to 1199 9 to 754   capped   746/797
(93 %)
14 diff
(98.3 %id)
BQ050095 lymph, lymphoma, cell line .a 557 to 1404 1 to 859   tiling clone,   859/1003
(85 %)
14 diff
(98.7 %id)
BX385349   .a 634 to 1126 1 to 494   AAA   494/573
(86 %)
14 diff
(97.6 %id)
BE315270 adenocarcinoma cell line, ovary .a 897 to 1572 8 to 677       670/806
(83 %)
22 diff
(97.3 %id)
BX328381   .a 907 to 1844 1 to 939       939/939
(100 %)
8 diff
(99.2 %id)
C05950   .a 1293 to 1853 1 to 568       566/578
(97 %)
20 diff
(96.6 %id)
TI_1948237363   .a 1767 to 2822 1192 to 124       1036/1347
(76 %)
97 diff
(92.8 %id)
TI_1948238044   .a 1801 to 2829 1147 to 119       1029/1340
(76 %)
33 diff
(97.6 %id)
TI_1948237804   .a 1858 to 2822 1095 to 122       765/1336
(57 %)
93 diff
(93.1 %id)
CA454893   .a 1893 to 2717 1 to 833       833/908
(91 %)
24 diff
(97.4 %id)
AK298778   .a 1912 to 3072 1 to 1161       1161/1161
(100 %)
0 diff
(100 %id)
DC365549   .a 1912 to 2539 1 to 628       628/628
(100 %)
0 diff
(100 %id)
DA819317   .a 1933 to 2486 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BX283899 Kidney, renal cell adenocarcinoma .a 1934 to 2453 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
BG424790 Kidney, renal cell adenocarcinoma .a 1934 to 2622 1 to 689       689/689
(100 %)
3 diff
(99.6 %id)
BX954492   .a 1940 to 2407 1 to 468       468/468
(100 %)
1 diff
(99.8 %id)
N88284   .a 1944 to 2289 1 to 344       344/344
(100 %)
8 diff
(97.7 %id)
TI_1948238043   .a 1968 to 2829 974 to 115       860/1283
(67 %)
9 diff
(99.3 %id)
CV571655 cornea, eye .a 2039 to 2612 1 to 574       574/574
(100 %)
0 diff
(100 %id)
TI_1948237364   .a 2052 to 2829 894 to 119       776/1249
(62 %)
33 diff
(97.4 %id)
BF229134 amnion_normal .a 2114 to 2411 323 to 26       298/323
(92 %)
1 diff
(99.7 %id)
DA134047 alzheimer cortex .a 2139 to 2620 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
DA134049 alzheimer cortex .a 2139 to 2712 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BF035453 adenocarcinoma, ovary .a 2185 to 2802 1 to 616       616/616
(100 %)
13 diff
(97.9 %id)
BX331185   .a 2228 to 2981 759 to 4       756/810
(93 %)
19 diff
(97.7 %id)
TI_1948237580   .a 2238 to 2829 1192 to 595     Submitted on the opposite strand 598/1218
(49 %)
46 diff
(96.3 %id)
BE465357 carcinoid, lung .a 2271 to 2804 1 to 534     Submitted on the opposite strand 534/534
(100 %)
0 diff
(100 %id)
CB157482 Liver .a 2403 to 3007 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
TI_1948237579   .a 2422 to 2829 997 to 589     Submitted on the opposite strand 409/1242
(32 %)
35 diff
(97.2 %id)
R79903 placenta .a 2472 to 2751 1 to 281   fully sequenced,   281/281
(100 %)
4 diff
(98.6 %id)
AW607400 head_neck .a 2506 to 2995 1 to 491       491/491
(100 %)
12 diff
(97.6 %id)
AW274828 pooled germ cell tumors .a 2532 to 3057 539 to 14   AAA   526/526
(100 %)
0 diff
(100 %id)
DB369648   .a 2537 to 3057 521 to 1       521/521
(100 %)
0 diff
(100 %id)
TI_57177803   .a 2560 to 3242 64 to 747       684/942
(72 %)
12 diff
(98.8 %id)
BI766297 pooled lung and spleen .a 2564 to 3242 1 to 680       680/875
(77 %)
6 diff
(99.4 %id)
FN059072 breast carcinoma .a 2612 to 2683 1 to 74       74/74
(100 %)
4 diff
(94.6 %id)
BG759946 B-cells, primary B-cells from tonsils (cell line) .a 2685 to 3368 1 to 690       690/823
(83 %)
20 diff
(97.6 %id)
R79804 placenta .a 2721 to 3057 344 to 1   fully sequenced,   344/344
(100 %)
10 diff
(97.1 %id)
EC546751 Prostate .a 2751 to 2841 11 to 102       92/102
(90 %)
6 diff
(94.2 %id)
DA020154   .a 2773 to 3334 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
AV738063 cord Blood .a 2809 to 3060 45 to 296       252/341
(73 %)
3 diff
(99.2 %id)
AV744288 cord Blood .a 2809 to 3056 45 to 292   AAA   248/292
(84 %)
6 diff
(98.0 %id)
CD654920 Embryonic Stem cells .a 3046 to 3795 1 to 747   tiling clone,   747/813
(91 %)
10 diff
(98.8 %id)
AW402969 lymph .a 3095 to 3490 1 to 397       397/397
(100 %)
6 diff
(98.5 %id)
TI_154139457   .a 3102 to 3735 79 to 714       636/636
(100 %)
10 diff
(98.5 %id)
BM091238 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 3167 to 3447 1 to 279       279/279
(100 %)
9 diff
(96.8 %id)
BX483082   .a 3189 to 3901 1 to 715       715/715
(100 %)
9 diff
(98.8 %id)
CD656279 Embryonic Stem cells .a 3208 to 3998 841 to 61   AAA Submitted on the opposite strand 781/807
(96 %)
11 diff
(98.7 %id)
CN268234 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3210 to 3633 1 to 423       423/423
(100 %)
2 diff
(99.6 %id)
AK056800 placenta .a 3279 to 5484 1 to 2204   tiling clone, available from FLJ,   2204/2204
(100 %)
3 diff
(99.9 %id)
DA838673 placenta .a 3280 to 3836 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
BM091541 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 3540 to 4057 518 to 1       518/518
(100 %)
4 diff
(99.3 %id)
TI_154151691   .a 3573 to 3998 526 to 101   AAA Submitted on the opposite strand 426/426
(100 %)
1 diff
(99.8 %id)
BU430356 lymph .a 3610 to 3998 417 to 29   AAA Submitted on the opposite strand 389/389
(100 %)
0 diff
(100 %id)
CF135488 lymph .a 3663 to 4254 7 to 596       590/596
(98 %)
6 diff
(99.0 %id)
TI_154163843   .a 3663 to 4263 68 to 666   AAA   599/829
(72 %)
23 diff
(97.3 %id)
BC000826 Placenta, choriocarcinoma .a 3757 to 4678 1 to 922   available from MGC, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 922/922
(100 %)
2 diff
(99.8 %id)
BG167832 hypernephroma, cell line, Kidney .a 3793 to 4571 1 to 772   tiling clone,   772/941
(82 %)
34 diff
(96.4 %id)
BX099862 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3814 to 4579 1 to 766   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 766/766
(100 %)
2 diff
(99.8 %id)
AA453726 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3814 to 4297 1 to 484   fully sequenced,   484/484
(100 %)
1 diff
(99.8 %id)
AL120242 amygdala .a 3834 to 4320 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
CV573139 cornea, eye .a 4000 to 4590 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
BU633532 cell lines, Chondrosarcoma .a 4036 to 4678 661 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
AW300356 Kidney .a 4053 to 4579 527 to 1       527/527
(100 %)
1 diff
(99.9 %id)
AA436101   .a 4074 to 4468 1 to 395   fully sequenced,   395/395
(100 %)
0 diff
(100 %id)
DA603385   .a 4194 to 4848 2 to 653   capped   652/652
(100 %)
2 diff
(99.7 %id)
FN115006 breast carcinoma .a 4215 to 4330 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
AI076445 liver and spleen .a 4221 to 4583 365 to 3       363/365
(99 %)
0 diff
(100 %id)
AA781017 parathyroid gland, parathyroid tumor .a 4227 to 4672 455 to 10       446/455
(98 %)
0 diff
(100 %id)
AA447795 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4267 to 4578 312 to 1   fully sequenced,   312/312
(100 %)
1 diff
(99.7 %id)
TI_154161899   .a 4304 to 4648 413 to 69     Submitted on the opposite strand 345/565
(61 %)
9 diff
(98.5 %id)
AW500757 lymph .a 4305 to 4649 351 to 7     Submitted on the opposite strand 345/351
(98 %)
0 diff
(100 %id)
AW505276 lymph .a 4305 to 4649 351 to 7     Submitted on the opposite strand 345/351
(98 %)
0 diff
(100 %id)
AW195373 Kidney .a 4331 to 4654 1 to 324     Submitted on the opposite strand 324/324
(100 %)
4 diff
(98.8 %id)
DN994686 brain, whole brain .a 4337 to 4949 5 to 618       614/618
(99 %)
6 diff
(99.1 %id)
GD141431   .a 4342 to 4520 184 to 6     Submitted on the opposite strand 179/187
(95 %)
0 diff
(100 %id)
BG106215 lymph, lymphoma, cell line .a 4397 to 5174 1 to 770   tiling clone,   770/992
(77 %)
24 diff
(97.6 %id)
AA228807   .a 4418 to 4676 264 to 6       259/264
(98 %)
0 diff
(100 %id)
FN155281 breast carcinoma .a 4420 to 4500 1 to 81       81/86
(94 %)
1 diff
(98.9 %id)
AA436002   .a 4438 to 4683 246 to 1   fully sequenced,   246/246
(100 %)
3 diff
(98.8 %id)
CF595704 Stomach, adenocarcinoma .a 4517 to 4671 1 to 155   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 155/155
(100 %)
3 diff
(98.1 %id)
DB328333 placenta .a 4951 to 5484 534 to 1       534/534
(100 %)
0 diff
(100 %id)
DB353472   .a 6026 to 6539 517 to 1   tiling clone,   517/526
(98 %)
7 diff
(98.7 %id)
BI562012 testis .b 1 to 753 1 to 757 F63L V64* tiling clone,   755/761
(99 %)
15 diff
(98.1 %id)
TI_44349921   .b 1 to 753 121 to 877 F63L V64*     755/881
(85 %)
18 diff
(98.0 %id)
DA185467 amygdala .c-u 1 to 345 2 to 349   tiling clone, capped   348/348
(100 %)
6 diff
(98.3 %id)
DA479979   .c-u 1253 to 1812 2 to 563 R40* tiling clone, capped   562/562
(100 %)
2 diff
(99.7 %id)
AI261281 Kidney .c-u 1284 to 1350 67 to 1       67/67
(100 %)
0 diff
(100 %id)
FN078419 breast carcinoma .c-u 1644 to 1741 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
AI870758 anaplastic oligodendroglioma, brain .c-u 1724 to 2158 436 to 1   tiling clone,   436/436
(100 %)
2 diff
(99.6 %id)
BF439825 pooled .c-u 1866 to 2164 317 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 299/299
(100 %)
0 diff
(100 %id)
AW130095 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c-u 2033 to 2158 141 to 16   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 126/126
(100 %)
2 diff
(98.5 %id)
BF037662 adenocarcinoma, ovary .c-u 2502 to 3217 1 to 717   tiling clone,   717/748
(95 %)
20 diff
(97.4 %id)
DB303127 amygdala .c-u 2668 to 3213 546 to 1   tiling clone,   546/546
(100 %)
0 diff
(100 %id)
AA302741 adipose tissue, white .c-u 2710 to 2964 1 to 256       256/264
(96 %)
2 diff
(99.3 %id)
BE467141 carcinoid, lung .c-u 2729 to 3215 487 to 1       487/487
(100 %)
0 diff
(100 %id)
CR740482   .c-u 2743 to 3213 1 to 471   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
AA482535 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c-u 2743 to 3008 1 to 266   fully sequenced,   266/266
(100 %)
0 diff
(100 %id)
BF110381 carcinoid, lung .c-u 2759 to 3216 459 to 2       458/459
(99 %)
0 diff
(100 %id)
AI090586 heart .c-u 2767 to 3213 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AA904456 pooled .c-u 2776 to 3216 442 to 2   tiling clone,   441/442
(99 %)
0 diff
(100 %id)
AW303313 pooled .c-u 2792 to 3216 426 to 2       425/426
(99 %)
0 diff
(100 %id)
AI824333 carcinoid, lung .c-u 2793 to 3216 427 to 4       424/427
(99 %)
0 diff
(100 %id)
R51339 whole brain .c-u 2807 to 3213 423 to 12   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 412/412
(100 %)
8 diff
(98.1 %id)
AI498737 anaplastic oligodendroglioma, brain .c-u 2819 to 3216 402 to 5       398/402
(99 %)
0 diff
(100 %id)
AI299427 carcinoid, lung .c-u 2897 to 3213 317 to 1       317/317
(100 %)
0 diff
(100 %id)
D80707.
matches multiple genes
brain .c-u 2962 to 3193 8 to 237     also hits gene DNM3 230/238
(96 %)
3 diff
(98.8 %id)
AA426403 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c-u 2978 to 3214 238 to 1   fully sequenced,   238/238
(100 %)
0 diff
(100 %id)
AI423881 pooled .c-u 3014 to 3213 200 to 1       200/200
(100 %)
0 diff
(100 %id)
AI686147 Prostate .c-u 3051 to 3215 165 to 1       165/165
(100 %)
0 diff
(100 %id)
BF476279 Prostate .c-u 3051 to 3215 165 to 1       165/165
(100 %)
0 diff
(100 %id)
AA906414 pooled .d 1 to 529 1 to 529     Submitted on the opposite strand 529/529
(100 %)
2 diff
(99.7 %id)
AI700211 pooled .d 1 to 547 1 to 547   tiling clone, Submitted on the opposite strand 547/547
(100 %)
0 diff
(100 %id)
AA426606 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 324 to 699 1 to 381       381/381
(100 %)
8 diff
(98.0 %id)
AA641743 germinal center B cell .d 439 to 826 393 to 5 L48V G60V A61Q G62A T63P ...   Submitted on the opposite strand 389/393
(98 %)
1 diff
(99.8 %id)
W04160 liver and spleen .d 484 to 982 9 to 501 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 493/501
(98 %)
18 diff
(96.5 %id)
AI189824 placenta .d 485 to 1005 521 to 1 P20R V21A F31L     521/521
(100 %)
4 diff
(99.3 %id)
CA436808 Bone, Subchondral Bone .d 493 to 1004 530 to 19 exact tiling clone, AAA   512/512
(100 %)
0 diff
(100 %id)
N58043 liver and spleen .d 500 to 984 487 to 1 D10X I30H I32H L33P L34S ...     487/487
(100 %)
5 diff
(99.0 %id)
AW444519   .d 516 to 978 480 to 18   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 463/463
(100 %)
1 diff
(99.8 %id)
BM993424 lung, Metastatic Chondrosarcoma .d 533 to 1004 490 to 19   AAA   472/472
(100 %)
6 diff
(98.8 %id)
CD708569 normal nasopharynx .d 569 to 1051 9 to 488   tiling clone,   480/488
(98 %)
10 diff
(98.0 %id)
AI950287 pooled germ cell tumors .d 587 to 1007 420 to 1       420/420
(100 %)
8 diff
(98.1 %id)
AW517905 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 602 to 1004 421 to 20   AAA   402/402
(100 %)
4 diff
(99.1 %id)
N70122 liver and spleen .d 605 to 984 380 to 1   fully sequenced, Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 380/380
(100 %)
2 diff
(99.5 %id)
T64907 liver and spleen .d 620 to 984 361 to 1       361/361
(100 %)
9 diff
(97.6 %id)
AW841631 colon_normal .e-u 1 to 325 21 to 343   tiling clone,   323/343
(94 %)
9 diff
(97.4 %id)
BG400248 Kidney .e-u 233 to 948 1 to 724 N9T C25W L26S C28M I29H ... tiling clone,   724/725
(99 %)
21 diff
(97.2 %id)
CN257833 embryonic stem cells, DMSO-treated H9 cellline .e-u 334 to 748 1 to 415   tiling clone,   415/415
(100 %)
1 diff
(99.8 %id)
AW444520   .e-u 589 to 1127 556 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 539/539
(100 %)
0 diff
(100 %id)
BF508078   .e-u 597 to 1127 548 to 18 exact AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 531/531
(100 %)
0 diff
(100 %id)
AI690142 carcinoid, lung .e-u 663 to 1126 464 to 1 exact     464/464
(100 %)
0 diff
(100 %id)
BF508079   .e-u 1026 to 1137 118 to 7   tiling clone,   112/118
(94 %)
0 diff
(100 %id)
CX871749 embryonic stem .f-u 1 to 809 1 to 809 exact tiling clone,   809/809
(100 %)
1 diff
(99.9 %id)
AW850280 colon .g-u 1 to 398 1 to 398   tiling clone,   398/398
(100 %)
1 diff
(99.8 %id)
AW850381 colon .g-u 2 to 398 1 to 397   tiling clone,   397/397
(100 %)
0 diff
(100 %id)
AW850383 colon .g-u 74 to 440 1 to 367   tiling clone,   367/368
(99 %)
10 diff
(97.3 %id)
AW850161 colon .g-u 175 to 398 224 to 1       224/224
(100 %)
2 diff
(99.2 %id)
AW850320 colon .g-u 210 to 398 189 to 1       189/189
(100 %)
1 diff
(99.5 %id)
AW377065 colon .g-u 415 to 605 1 to 191       191/191
(100 %)
1 diff
(99.5 %id)
AW752705 colon .g-u 415 to 777 367 to 5 exact tiling clone,   363/367
(98 %)
0 diff
(100 %id)
AW752742 colon .g-u 415 to 777 379 to 17 exact     363/379
(95 %)
0 diff
(100 %id)
AW850281 colon .g-u 415 to 539 1 to 125       125/125
(100 %)
0 diff
(100 %id)
AL701278 human skeletal muscle .h 1 to 602 1 to 602 exact tiling clone,   602/602
(100 %)
0 diff
(100 %id)
BE167225 head_neck .i 1 to 538 547 to 10 R4G D6N tiling clone, Submitted on the opposite strand 538/548
(98 %)
2 diff
(99.7 %id)
BE939955 uterus_tumor .j-u 1 to 408 463 to 56 H3P L4F K5Q tiling clone,   408/479
(85 %)
0 diff
(100 %id)
AW976606   Gene ATP6V0A2, variant not shown         Submitted on the opposite strand    
AA731170 germinal center B cell Gene ATP6V0A2, variant not shown         This clone was ignored    
AA721667 germinal center B cell Gene ATP6V0A2, variant not shown         This clone was ignored    
BE890750 melanotic melanoma, skin Gene ATP6V0A2, variant not shown         Suspected internal deletion, this clone was ignored    
BC022300 Prostate, adenocarcinoma. Gene ATP6V0A2, variant not shown       available from MGC, AAA This clone was ignored    
BU076635 Pancreas, Purified pancreatic islet Gene ATP6V0A2, variant not shown         This clone was ignored    
BU074474 Pancreas, Purified pancreatic islet Gene ATP6V0A2, variant not shown         This clone was ignored    
BU074758 Pancreas, Purified pancreatic islet Gene ATP6V0A2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e-u, .f-u, .g-u, .h, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI